A New Insight Into the Potential Role of Tryptophan-Derived Ahr Ligands in Skin Physiological and Pathological Processes

Total Page:16

File Type:pdf, Size:1020Kb

A New Insight Into the Potential Role of Tryptophan-Derived Ahr Ligands in Skin Physiological and Pathological Processes International Journal of Molecular Sciences Review A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes Monika Szelest †,‡ , Katarzyna Walczak *,† and Tomasz Plech Department of Pharmacology, Medical University of Lublin, Chod´zki4a, 20-093 Lublin, Poland; [email protected] (M.S.); [email protected] (T.P.) * Correspondence: [email protected]; Tel.: +48-81-448-6774 † These authors contributed equally to this work. ‡ A Volunteer in the Department of Pharmacology, Medical University of Lublin. Abstract: The aryl hydrocarbon receptor (AhR) plays a crucial role in environmental responses and xenobiotic metabolism, as it controls the transcription profiles of several genes in a ligand- specific and cell-type-specific manner. Various barrier tissues, including skin, display the expression of AhR. Recent studies revealed multiple roles of AhR in skin physiology and disease, includ- ing melanogenesis, inflammation and cancer. Tryptophan metabolites are distinguished among the groups of natural and synthetic AhR ligands, and these include kynurenine, kynurenic acid and 6-formylindolo[3,2-b]carbazole (FICZ). Tryptophan derivatives can affect and regulate a variety of signaling pathways. Thus, the interest in how these substances influence physiological and patholog- ical processes in the skin is expanding rapidly. The widespread presence of these substances and potential continuous exposure of the skin to their biological effects indicate the important role of AhR and its ligands in the prevention, pathogenesis and progression of skin diseases. In this review, we summarize the current knowledge of AhR in skin physiology. Moreover, we discuss the role of AhR in skin pathological processes, including inflammatory skin diseases, pigmentation disorders and Citation: Szelest, M.; Walczak, K.; cancer. Finally, the impact of FICZ, kynurenic acid, and kynurenine on physiological and pathological Plech, T. A New Insight into processes in the skin is considered. However, the mechanisms of how AhR regulates skin function the Potential Role of require further investigation. Tryptophan-Derived AhR Ligands in Skin Physiological and Keywords: aryl hydrocarbon receptor; tryptophan; kynurenine; FICZ; skin; kynurenic acid; atopic Pathological Processes. Int. J. Mol. Sci. dermatitis; psoriasis; melanoma 2021, 22, 1104. https://doi.org/ 10.3390/ijms22031104 Received: 29 November 2020 1. Introduction Accepted: 19 January 2021 Published: 22 January 2021 The aryl hydrocarbon receptor (AhR) is expressed in various tissues characterized by a rapid growth rate, including skin [1]. Gene expression analysis revealed that AhR activation enhances or suppresses the expression of several genes, thus influencing the gene Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in expression profile [2]. Previous studies revealed the crucial role of AhR in several physio- published maps and institutional affil- logical and pathological processes in the skin. Among the groups of natural and synthetic iations. AhR ligands is the group of tryptophan derivatives [1,3]. Some of them, including kynure- nine, kynurenic acid, and 6-formylindolo[3,2-b]carbazole (FICZ), have been previously recognized as ligands of this receptor. However, recently discovered biological properties of these substances, their widespread presence, and potential continuous exposure may suggest the important role of tryptophan-derived AhR ligands in many physiological and Copyright: © 2021 by the authors. pathological processes in the skin [4]. Unfortunately, the role of AhR itself and the biological Licensee MDPI, Basel, Switzerland. This article is an open access article effect of the tryptophan-derived ligands in the prevention, pathogenesis, and progression distributed under the terms and of skin diseases are not fully understood to date. conditions of the Creative Commons 2. Aryl Hydrocarbon Receptor (AhR) Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ AhR is a transcription factor from the evolutionarily old family of a basic helix-loop- 4.0/). helix/Per-ARNT-Sim (bHLH-PAS) transcription regulators, acting in a DNA sequence- Int. J. Mol. Sci. 2021, 22, 1104. https://doi.org/10.3390/ijms22031104 https://www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 2 of 30 Int. J. Mol. Sci. 2021, 22, 1104 2. Aryl Hydrocarbon Receptor (AhR) 2 of 31 AhR is a transcription factor from the evolutionarily old family of a basic helix-loop- helix/Per-ARNT-Sim (bHLH-PAS) transcription regulators, acting in a DNA sequence- specificspecific manner.manner. The bHLH motif contains two domains that areare responsibleresponsible forfor DNADNA sequence bindingbinding andand proteinprotein dimerizationdimerization [[1].1]. SeveralSeveral low-molecular-weightlow-molecular-weight chemicalchemical compounds activateactivate thethe cytosoliccytosolic AhRAhR afterafter enteringentering cellscells viavia diffusiondiffusion [[3,5].3,5]. AirAir pollutionpollution compounds [[3],3], endogenousendogenous amino amino acid acid derivatives derivatives [6 –[6–8],8], some some food food components components (e.g., (e.g., in- doles,indoles, polyphenols, polyphenols, glucosinolates) glucosinolates) [9 [9–11],–11], and and some some yeast yeast and and bacterial bacterial metabolites metabolites [[12]12] are considered AhR ligands. ligands. AhR AhR has has only only one one binding binding pocket, pocket, whose whose amino amino acid acid compo- com- positionsition determines determines ligand ligand binding binding strength strength [1]; [1 however,]; however, AhR AhR may may also also be be activated activated by by a anumber number of of stress stress factors factors and and some some substances substances that that might might not not fit fit into the bindingbinding pocketpocket (e.g.,(e.g., hypoxiahypoxia andand oxidizedoxidized low-densitylow-density lipoproteins)lipoproteins) [[13].13]. The type of AhR ligand determinesdetermines thethe levellevel ofof activationactivation andand thethe spectrumspectrum ofof genesgenes transcribedtranscribed [[14–16].14–16]. An increased AHR expression is observed in the placenta, placenta, liver, lungs, intestines,intestines, and and skin, skin, which which are are barrier barrier tissues tissues or orplay play an animportant important role role in metabolism. in metabolism. The Thelowest lowest AHRAHR expressionexpression is reported is reported in the in thebrain, brain, kidneys, kidneys, and and skeletal skeletal muscles muscles [2]. [Recent2]. Re- centstudies studies revealed revealed additional additional functions functions of AhR of AhR in inthe the body, body, including including control control of of liver andand vascularvascular development, intestinal immunity, hematopoiesis,hematopoiesis, and perinatal growth [17–22]. [17–22]. Moreover, AhRAhR signalingsignaling maymay bebe associatedassociated withwithstem stemcell cell proliferation proliferation and and carcinogene- carcinogen- sisesis [ 2[2].]. After ligand binding, binding, AhR AhR di dissociatesssociates from from its its chaperones chaperones (e.g., (e.g., proto-oncogene proto-oncogene ty- tyrosine-proteinrosine-protein kinase kinase c-Src, c-Src, heat heat shock shock protei proteinn 90 (HSP90), 90 (HSP90), p23, p23,and the and hepatitis the hepatitis B virus B virusX-associated X-associated protein protein 2 (XAP2)) 2 (XAP2)) and undergoes and undergoes conformational conformational changes, changes, resulting resulting in the inexposition the exposition of the nuclear of the nuclear translocation translocation signal and signal induction and induction of AhR of transport AhR transport into the into nu- thecleus nucleus (Figure (Figure 1A) [23].1A) [23]. Figure 1. Schematic overview overview of of aryl aryl hydrocarbon hydrocarbon receptor receptor (AhR) (AhR) signaling signaling pathways: pathways: canonical canonical (A) and noncanonical(A) and noncanonical (B). In physiological (B). In physiological conditions, AhRconditions, is localized AhR in is the localized cytosol in and the complexed cytosol and with com- specific proteins,plexed with such specific as the hepatitis proteins, B virussuch X-associatedas the hepati proteintis B virus 2 (XAP-2), X-associated heat shock protein protein 2 (XAP-2), 90 (HSP90), heat c-Src andshock p23. protein Upon 90 ligand (HSP90), binding, c-Src AhR and changes p23. Upon its conformation ligand binding, and isAhR translocated changes toits the conformation nucleus, where and it dimerizes with AhR nuclear transporter (ARNT) (A) or other partners, such as transcription factors (e.g., Kruppel-like factor 6 (KLF6)). (B). Dissociated c-Src interacts with the epidermal growth factor receptor (EGFR). To date, several different types of crosstalk between AhR and other proteins have been described. Int. J. Mol. Sci. 2021, 22, 1104 3 of 31 For instance, AhR interaction with the hyperphosphorylated form of the retinoblastoma protein (Rb) results in growth arrest at the G1/S phase of the cell cycle [24]. AhR signaling may also pro- mote nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) activation via RelA and RelB interaction [25–27]. Moreover, AhR signaling is associated with the activity and function of the estrogen receptor [28]. The AhR/ARNT complex binds to the xenobiotic-responsive element (XRE) and induces the transcription of AhR-responsive genes (e.g., CYP1A1). On the other hand, AhR ligation promotes the transcription of its
Recommended publications
  • Rational Design of Resveratrol O-Methyltransferase for the Production of Pinostilbene
    International Journal of Molecular Sciences Article Rational Design of Resveratrol O-methyltransferase for the Production of Pinostilbene Daniela P. Herrera 1 , Andrea M. Chánique 1,2 , Ascensión Martínez-Márquez 3, Roque Bru-Martínez 3 , Robert Kourist 2 , Loreto P. Parra 4,* and Andreas Schüller 4,5,* 1 Department of Chemical and Bioprocesses Engineering, School of Engineering, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Santiago 7820244, Chile; [email protected] (D.P.H.); [email protected] (A.M.C.) 2 Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, 8010 Graz, Austria; [email protected] 3 Department of Agrochemistry and Biochemistry, Faculty of Science and Multidisciplinary Institute for Environmental Studies “Ramon Margalef”, University of Alicante, 03690 Alicante, Spain; [email protected] (A.M.-M.); [email protected] (R.B.-M.) 4 Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Santiago 7820244, Chile 5 Department of Molecular Genetics and Microbiology, School of Biological Sciences, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins 340, Santiago 8320000, Chile * Correspondence: [email protected] (L.P.P.); [email protected] (A.S.) Abstract: Pinostilbene is a monomethyl ether analog of the well-known nutraceutical resveratrol. Both compounds have health-promoting properties, but the latter undergoes rapid metabolization and has low bioavailability. O-methylation improves the stability and bioavailability of resveratrol. In plants, these reactions are performed by O-methyltransferases (OMTs). Few efficient OMTs that Citation: Herrera, D.P.; Chánique, monomethylate resveratrol to yield pinostilbene have been described so far.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • R Graphics Output
    Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 )
    [Show full text]
  • Chlorinated and Polycyclic Aromatic Hydrocarbons in Riverine and Estuarine Sediments from Pearl River Delta, China
    Environmental Pollution 117 (2002) 457–474 www.elsevier.com/locate/envpol Chlorinated and polycyclic aromatic hydrocarbons in riverine and estuarine sediments from Pearl River Delta, China Bi-Xian Maia,*, Jia-Mo Fua, Guo-Ying Shenga, Yue-Hui Kanga, Zheng Lina, Gan Zhanga, Yu-Shuan Mina, Eddy Y. Zengb aState Key Lab Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, PO Box 1130, Guangzhou, Guangdong 510640, People’s Republic of China bSouthern California Coastal Water Research Project, 7171 Fenwick Lane, Westminster, CA 92683, USA Received 5 January 2001; accepted 3 July 2001 ‘‘Capsule’’: Sediments of the Zhujiang River and Macao Harbor have the potential to be detrimental to biological systems. Abstract Spatial distribution of chlorinated hydrocarbons [chlorinated pesticides (CPs) and polychlorinated biphenyls (PCBs)] and poly- cyclic aromatic hydrocarbons (PAHs) was measured in riverine and estuarine sediment samples from Pearl River Delta, China, collected in 1997. Concentrations of CPs of the riverine sediment samples range from 12 to 158 ng/g, dry weight, while those of PCBs range from 11 to 486 ng/g. The CPs concentrations of the estuarine sediment samples are in the range 6–1658 ng/g, while concentrations of PCBs are in the range 10–339 ng/g. Total PAH concentration ranges from 1168 to 21,329 ng/g in the riverine sediment samples, whereas the PAH concentration ranges from 323 to 14,812ng/g in the sediment samples of the Estuary. Sediment samples of the Zhujiang River and Macao harbor around the Estuary show the highest concentrations of CPs, PCBs, and PAHs. Possible factors affecting the distribution patterns are also discussed based on the usage history of the chemicals, hydrologic con- dition, and land erosion due to urbanization processes.
    [Show full text]
  • Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium Fortunei
    International Journal of Molecular Sciences Article Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium fortunei Chun-Hao Chang 1, Semon Wu 2, Kai-Cheng Hsu 3,4, Wei-Jan Huang 5,6 and Jih-Jung Chen 7,8,9,* 1 Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan; [email protected] 2 Department of Life Science, Chinese Culture University, Taipei 110, Taiwan; [email protected] 3 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan; [email protected] 4 Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan 5 Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; [email protected] 6 Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan 7 Department of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan 8 Faculty of Pharmacy, National Yang-Ming University, Taipei 112, Taiwan 9 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2826-7195; Fax: +886-2-2823-2940 Abstract: Five new compounds, eupatodibenzofuran A (1), eupatodibenzofuran B (2), 6-acetyl-8- methoxy-2,2-dimethylchroman-4-one (3), eupatofortunone (4), and eupatodithiecine (5), have been isolated from the aerial part of Eupatorium fortunei, together with 11 known compounds (6-16).
    [Show full text]
  • WO 2013/064736 Al 10 May 2013 (10.05.2013) P O P CT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2013/064736 Al 10 May 2013 (10.05.2013) P O P CT (51) International Patent Classification: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, C12N 9/10 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (21) International Application Number: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, PCT/FI2012/05 1048 ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (22) International Filing Date: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, 3 1 October 2012 (3 1.10.2012) RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (25) Filing Language: English ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 201 16074 1 November 201 1 (01. 11.201 1) FI GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (71) Applicant: VALIO LTD [FI/FI]; Meijeritie 6, FI-00370 TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Helsinki (FI). EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (72) Inventors: RAJAKARI, Kirsi; c/o Valio Ltd, Meijeritie 6, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, FI-00370 Helsinki (FI).
    [Show full text]
  • Biosynthetic Investigation of Phomopsins Reveals a Widespread Pathway for Ribosomal Natural Products in Ascomycetes
    Biosynthetic investigation of phomopsins reveals a widespread pathway for ribosomal natural products in Ascomycetes Wei Dinga, Wan-Qiu Liua, Youli Jiaa, Yongzhen Lia, Wilfred A. van der Donkb,c,1, and Qi Zhanga,b,1 aDepartment of Chemistry, Fudan University, Shanghai 200433, China; bDepartment of Chemistry, University of Illinois at Urbana–Champaign, Urbana, IL 61801; and cHoward Hughes Medical Institute, University of Illinois at Urbana–Champaign, Urbana, IL 61801 Edited by Jerrold Meinwald, Cornell University, Ithaca, NY, and approved February 23, 2016 (received for review November 24, 2015) Production of ribosomally synthesized and posttranslationally mod- dehydroaspartic acid, 3,4-dehydroproline, and 3,4-dehydrovaline ified peptides (RiPPs) has rarely been reported in fungi, even (Fig. 1A). though organisms of this kingdom have a long history as a prolific Early isotopic labeling studies showed that Ile, Pro, and Phe were source of natural products. Here we report an investigation of the all incorporated into the phomopsin scaffold (24). Because a Phe phomopsins, antimitotic mycotoxins. We show that phomopsin is a hydroxylase that can convert Phe to Tyr has not been found in fungal RiPP and demonstrate the widespread presence of a path- Ascomycetes, the labeling study seems incongruent with a ribosomal way for the biosynthesis of a family of fungal cyclic RiPPs, which we route to phomopsins, in which Tyr, not Phe, would need to be in- term dikaritins. We characterize PhomM as an S-adenosylmethionine– corporated into the phomopsin structure via a tRNA-dependent dependent α-N-methyltransferase that converts phomopsin A to pathway. Here we report our investigation of the biosynthetic path- an N,N-dimethylated congener (phomopsin E), and show that the way of phomopsins, which explains the paradoxical observations in methyltransferases involved in dikaritin biosynthesis have evolved the early labeling studies and unequivocally demonstrates that pho- differently and likely have broad substrate specificities.
    [Show full text]
  • National Coverage Determination Procedure Code: 82977 Gamma Glutamyl Transferase CMS Policy Number: 190.32 Back to NCD List
    National Coverage Determination Procedure Code: 82977 Gamma Glutamyl Transferase CMS Policy Number: 190.32 Back to NCD List Description: Gamma glutamyl transferase (GGT) is an intracellular enzyme that appears in blood following leakage from cells. Renal tubules, liver, and pancreas contain high amounts, although the measurement of GGT in serum is almost always used for assessment of Hepatobiliary function. Unlike other enzymes which are found in heart, skeletal muscle, and intestinal mucosa as well as liver, the appearance of an elevated level of GGT in serum is almost always the result of liver disease or injury. It is specifically useful to differentiate elevated alkaline phosphatase levels when the source of the alkaline phosphatase increase (bone, liver, or placenta) is unclear. The combination of high alkaline phosphatase and a normal GGT does not, however, rule out liver disease completely. As well as being a very specific marker of Hepatobiliary function, GGT is also a very sensitive marker for hepatocellular damage. Abnormal concentrations typically appear before elevations of other liver enzymes or biliuria are evident. Obstruction of the biliary tract, viral infection (e.g., hepatitis, mononucleosis), metastatic cancer, exposure to hepatotoxins (e.g., organic solvents, drugs, alcohol), and use of drugs that induce microsomal enzymes in the liver (e.g., cimetidine, barbiturates, phenytoin, and carbamazepine) all can cause a moderate to marked increase in GGT serum concentration. In addition, some drugs can cause or exacerbate liver dysfunction (e.g., atorvastatin, troglitazone, and others as noted in FDA Contraindications and Warnings.) GGT is useful for diagnosis of liver disease or injury, exclusion of hepatobiliary involvement related to other diseases, and patient management during the resolution of existing disease or following injury.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Relating Metatranscriptomic Profiles to the Micropollutant
    1 Relating Metatranscriptomic Profiles to the 2 Micropollutant Biotransformation Potential of 3 Complex Microbial Communities 4 5 Supporting Information 6 7 Stefan Achermann,1,2 Cresten B. Mansfeldt,1 Marcel Müller,1,3 David R. Johnson,1 Kathrin 8 Fenner*,1,2,4 9 1Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, 10 Switzerland. 2Institute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 11 Zürich, Switzerland. 3Institute of Atmospheric and Climate Science, ETH Zürich, 8092 12 Zürich, Switzerland. 4Department of Chemistry, University of Zürich, 8057 Zürich, 13 Switzerland. 14 *Corresponding author (email: [email protected] ) 15 S.A and C.B.M contributed equally to this work. 16 17 18 19 20 21 This supporting information (SI) is organized in 4 sections (S1-S4) with a total of 10 pages and 22 comprises 7 figures (Figure S1-S7) and 4 tables (Table S1-S4). 23 24 25 S1 26 S1 Data normalization 27 28 29 30 Figure S1. Relative fractions of gene transcripts originating from eukaryotes and bacteria. 31 32 33 Table S1. Relative standard deviation (RSD) for commonly used reference genes across all 34 samples (n=12). EC number mean fraction bacteria (%) RSD (%) RSD bacteria (%) RSD eukaryotes (%) 2.7.7.6 (RNAP) 80 16 6 nda 5.99.1.2 (DNA topoisomerase) 90 11 9 nda 5.99.1.3 (DNA gyrase) 92 16 10 nda 1.2.1.12 (GAPDH) 37 39 6 32 35 and indicates not determined. 36 37 38 39 S2 40 S2 Nitrile hydration 41 42 43 44 Figure S2: Pearson correlation coefficients r for rate constants of bromoxynil and acetamiprid with 45 gene transcripts of ECs describing nucleophilic reactions of water with nitriles.
    [Show full text]
  • The Neurochemical Consequences of Aromatic L-Amino Acid Decarboxylase Deficiency
    The neurochemical consequences of aromatic L-amino acid decarboxylase deficiency Submitted By: George Francis Gray Allen Department of Molecular Neuroscience UCL Institute of Neurology Queen Square, London Submitted November 2010 Funded by the AADC Research Trust, UK Thesis submitted for the degree of Doctor of Philosophy, University College London (UCL) 1 I, George Allen confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Signed………………………………………………….Date…………………………… 2 Abstract Aromatic L-amino acid decarboxylase (AADC) catalyses the conversion of 5- hydroxytryptophan (5-HTP) and L-3,4-dihydroxyphenylalanine (L-dopa) to the neurotransmitters serotonin and dopamine respectively. The inherited disorder AADC deficiency leads to a severe deficit of serotonin and dopamine as well as an accumulation of 5-HTP and L-dopa. This thesis investigated the potential role of 5- HTP/L-dopa accumulation in the pathogenesis of AADC deficiency. Treatment of human neuroblastoma cells with L-dopa or dopamine was found to increase intracellular levels of the antioxidant reduced glutathione (GSH). However inhibiting AADC prevented the GSH increase induced by L-dopa. Furthermore dopamine but not L-dopa, increased GSH release from human astrocytoma cells, which do not express AADC activity. GSH release is the first stage of GSH trafficking from astrocytes to neurons. This data indicates dopamine may play a role in controlling brain GSH levels and consequently antioxidant status. The inability of L-dopa to influence GSH concentrations in the absence of AADC or with AADC inhibited indicates GSH trafficking/metabolism may be compromised in AADC deficiency.
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]